[Expression and Clinical Significance of Serum HDAC2 in Patients with Acute Myeloid Leukemia].

The expression level of serum HDAC2 in AML patients is increased, which has positive correlations with IL-6, TNF-α, IL-1β and CRP. HDAC2 is an independent risk factor for the poor prognosis of AML patients, and has a high predictive value.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-10-01
DOI
https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.003
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Expression and Clinical Significance of Serum HDAC2 in Patients with Acute Myeloid Leukemia].

Jing Huang, Jingjing Yang, Yanchao Xu, Huiqi Zhang
PubMed
Histone Deacetylase Inhibitors Research
article

[Expression and Clinical Significance of Serum HDAC2 in Patients with Acute Myeloid Leukemia].

Jing Huang, Jingjing Yang, Yanchao Xu, Huiqi Zhang
article en

Abstract

The expression level of serum HDAC2 in AML patients is increased, which has positive correlations with IL-6, TNF-α, IL-1β and CRP. HDAC2 is an independent risk factor for the poor prognosis of AML patients, and has a high predictive value.

PubMedVol. 32(5)
Huzhou Central Hospital (CN), Third People's Hospital of Huzhou (CN)
Histone Deacetylase Inhibitors Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.